Unprovoked recurrent venous thrombosis: prediction by D-dimer and clinical risk factors

被引:48
作者
Baglin, T. [1 ]
Palmer, C. R. [2 ]
Luddington, R. [1 ]
Baglin, C. [1 ]
机构
[1] Univ Cambridge, Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0QQ, England
[2] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Appl Med Stat, Cambridge, England
关键词
D-dimer; deep vein thrombosis; pulmonary embolus; recurrence; thrombosis;
D O I
10.1111/j.1538-7836.2008.02889.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The aim of the study was to determine the predictive value of D-dimer measurement for unprovoked recurrent venous thrombosis and the influence of sex, age and type of first event (unprovoked or provoked). Methods: Prospective cohort study of 272 patients with a first episode of venous thrombosis that was unprovoked or provoked by a non-surgical trigger. Findings: The cumulative rate of unprovoked recurrence in patients with a positive D-dimer was 20% at 5 years [5.5/100 patient-years, 95% confidence interval (CI) 3.7-7.8] and in patients with a negative D-dimer 17% (4.1/100 patient-years, 95% CI 2.3-6.9). The rates are not different (hazard ratio 1.3, 95% CI 0.7-2.5). After adjustment for clinical risk factors a positive D-dimer result was significantly associated with an increased risk of unprovoked recurrent thrombosis (hazard ratio 2.0, 95% CI 1.01-3.9). The strongest indicator of risk of recurrence was male sex (hazard ratio 3.3 unadjusted and 2.9 after adjustment). The only determinant of D-dimer in a linear regression model was age (P < 0.001). Conclusions: The analysis indicates that clinical risk factors confound the association between D-dimer and risk of recurrence and when adjusted for these confounders a positive D-dimer result is significantly associated with unprovoked recurrence. The clinical utility of D-dimer measurement in individual patients should be interpreted in conjunction with clinical risk factors.
引用
收藏
页码:577 / 582
页数:6
相关论文
共 18 条
[1]   Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis: not yet [J].
Baglin, T. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (12) :2530-2532
[2]   Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study [J].
Baglin, T ;
Luddington, R ;
Brown, K ;
Baglin, C .
LANCET, 2003, 362 (9383) :523-526
[3]   STATISTICAL-METHODS FOR CLINICAL-TRIALS [J].
BAILEY, A ;
CROOK, A ;
MACHIN, D .
BLOOD REVIEWS, 1994, 8 (02) :105-112
[4]  
Brito-Babapulle V, 1998, BRIT J HAEMATOL, V101, P43
[5]   Antithrombotic therapy for venous thromboembolic disease [J].
Büller, HR ;
Agnelli, G ;
Hull, RD ;
Hyers, TA ;
Prins, AH ;
Raskob, GE .
CHEST, 2004, 126 (03) :401S-428S
[6]   Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis: yes [J].
Cosmi, B. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (12) :2527-2529
[7]   Risk of fatal pulmonary embolism in patients with treated venous thromboembolism [J].
Douketis, JD ;
Kearon, C ;
Bates, S ;
Duku, EK ;
Ginsberg, JS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (06) :458-462
[8]   D-dimer levels and risk of recurrent venous thromboembolism [J].
Eichinger, S ;
Minar, E ;
Bialonczyk, C ;
Hirschl, M ;
Quehenberger, P ;
Schneider, B ;
Weltermann, A ;
Wagner, O ;
Kyrle, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (08) :1071-1074
[9]   The post-thrombotic syndrome: current knowledge, controversies, and directions for future research [J].
Kahn, SR ;
Ginsberg, JS .
BLOOD REVIEWS, 2002, 16 (03) :155-165
[10]   Natural history of venous thromboembolism [J].
Kearon, C .
CIRCULATION, 2003, 107 :I22-I30